The facts that (i) PACAP38 and PAC1R are present in human retinoblastoma and that (ii) PACAP38 and its analogs had a cytotoxic effect on retinoblastoma cells suggest the potential role of PACAP38 and its analogs in retinoblastoma therapy. This evidence concerns the gene ADCYAP1R1 and retinoblastoma.